Stock Price Quote

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE1339.65-5.2 (-0.39 %)
PREV CLOSE ( ) 1344.85
OPEN PRICE ( ) 1358.00
BID PRICE (QTY) 1338.05 (1)
OFFER PRICE (QTY) 1340.00 (10)
VOLUME 440
TODAY'S LOW / HIGH ( )1325.10 1358.00
52 WK LOW / HIGH ( )1131.05 1745
NSE1336.45-8.2 (-0.61 %)
PREV CLOSE( ) 1344.65
OPEN PRICE ( ) 1351.00
BID PRICE (QTY) 1336.55 (10)
OFFER PRICE (QTY) 1338.85 (10)
VOLUME 8848
TODAY'S LOW / HIGH( ) 1325.00 1353.00
52 WK LOW / HIGH ( )1130 1748
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-11 1924
Management Info
R S Karnad - Chairman A Vaidheesh - Managing Director
Registered Office

Address Dr Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email askus@gsk.com

Website www.gsk-india.com

Registrars Details
KFIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

04Feb Glaxosmithkline Pharmaceuticals report
Glaxosmithkline Pharmaceuticals has reported results for third quarter e..
23Jan GlaxoSmithKline Pharmaceuticals inform
Pursuant to Regulation 39 and other application regulations of SEBI (Lis..
17Jan Glaxosmithkline Pharmaceuticals inform
Glaxosmithkline Pharmaceuticals has informed that pursuant to Regulation..
23Oct Glaxosmithkline Pharmaceuticals report
Glaxosmithkline Pharmaceuticals has reported results for second quarter..
26Sep GlaxoSmithkline Pharmaceuticals recall
GlaxoSmithkline Pharmaceuticals has recalled ranitidine hydrochloride ta..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit-6441.44253.6
Gross Profit -6173.1 6637.1
Operating Profit 14097079.6
Net Sales 7786.831285.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  7415.20 (1.26%)
M.Cap ( in Cr)17034.37
Solara Active Pharma (BSE)
peergroup  719.50 (5.77%)
M.Cap ( in Cr)1844.06
Jenburkt Pharma (BSE)
peergroup  405.50 (9.27%)
M.Cap ( in Cr)188.16
Astrazeneca Pharma I (BSE)
peergroup  2829.00 (0.96%)
M.Cap ( in Cr)7053.50
Shilpa Medicare (BSE)
peergroup  490.70 (5.00%)
M.Cap ( in Cr)4000.52

Shareholding Pattern

PROMOTERS 75%
FI/BANKS/INSURANCE 7.05%
MUTUAL FUNDS/UTI 3.97%
NON-INSTITUTION 13.47%
FII 0%
GOVERNMENT 0%

About Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd. was incorporated in the year 1924. Its today's share price is 1344.85. Its current market capitalisation stands at Rs 22584.37 Cr. In the latest quarter, company has reported Gross Sales of Rs. 31281.19 Cr and Total Income of Rs.32304.36 Cr. The company's management includes S Williams, P Thakur, D Sundaram, A N Roy, R Krishnaswamy, N Kaviratne ( C B E ), PV Bhide, A Bansal, A Vaidheesh, R S Karnad.

It is listed on the BSE with a BSE Code of 500660 , NSE with an NSE Symbol of GLAXO and ISIN of INE159A01016. It's Registered office is at Dr Annie Besant Road,Worli,Mumbai-400030, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, Lovelock & Lewes, Price Waterhouse & Co, Price Waterhouse & Co Bangalore LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X